If you made any changes in Pure these will be visible here soon.

Research Output 1989 2020

2020

Denosumab in early breast cancer: negative data and a call to action

Perrone, F. & Gravina, A., Jan 2020, In : The Lancet Oncology. 21, 1, p. 5-6 2 p.

Research output: Contribution to journalComment/debate

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018

Reale, M. L., De Luca, E., Lombardi, P., Marandino, L., Zichi, C., Pignataro, D., Ghisoni, E., Di Stefano, R. F., Mariniello, A., Trevisi, E., Leone, G., Muratori, L., La Salvia, A., Sonetto, C., Bironzo, P., Aglietta, M., Novello, S., Scagliotti, G. V., Perrone, F. & Di Maio, M., Jan 2020, In : Lung Cancer. 139, p. 47-54 8 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Quality of Life
Publications
Life Expectancy

Real-World Evidence in Oncology: Opportunities and Limitations

Di Maio, M., Perrone, F. & Conte, P., 2020, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalComment/debate

2019

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., 2019, In : European Journal of Cancer.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., Sep 1 2019, In : European Journal of Cancer. 118, p. 178-186 9 p.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival

Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy

Trotta, F., Mayer, F., Barone-Adesi, F., Esposito, I., Punreddy, R., Da Cas, R., Traversa, G., Perrone, F., Martini, N., Gyawali, B. & Addis, A., Dec 10 2019, In : BMJ Open. 9, 12, p. e033728

Research output: Contribution to journalArticle

Open Access
Italy
Cross-Sectional Studies
Pharmaceutical Preparations
Negotiating
Disease-Free Survival

Assessing financial toxicity in patients with cancer: Moving away from a one-size-fits-all approach

Perrone, F., Di Maio, M., Efficace, F., Gallo, C., Giannarelli, D., Montesarchio, V. & Riva, S., Aug 1 2019, In : Journal of Oncology Practice. 15, 8, p. 460-461 2 p.

Research output: Contribution to journalLetter

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology

Pascarella, G., Capasso, A., Nardone, A., Triassi, M., Pignata, S., Arenare, L., Ascierto, P., Curvietto, M., Maiolino, P., D’Aniello, R., Montanino, A., Laudato, F., De Feo, G., Botti, G., Perrone, F., Petrillo, A., Cavalcanti, E., Lastoria, S., Maurea, N. & Morabito, A., Jan 1 2019, In : PLoS One. 14, 1, e0210330.

Research output: Contribution to journalArticle

Biological Factors
Antineoplastic Agents
clinical trials
Clinical Trials
Costs and Cost Analysis

Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: A protocol

Riva, S., Bryce, J., De Lorenzo, F., Del Campo, L., Di Maio, M., Efficace, F., Frontini, L., Giannarelli, D., Gitto, L., Iannelli, E., Jommi, C., Montesarchio, V., Traclò, F., Vaccaro, C. M., Gallo, C. & Perrone, F., Sep 1 2019, In : BMJ Open. 9, 9, e031485.

Research output: Contribution to journalArticle

Italy
Bankruptcy
Neoplasms
Quality of Life
Universal Coverage

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C. & 10 others, Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F. & Gridelli, C., Jul 1 2019, In : Lung Cancer. 133, p. 62-68 7 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cisplatin
Quality of Life
Drug Therapy
Mouth

Negative hyperselection of patients with RAS and BRAF wild-type metastatic colorectal cancer who received panitumumab-based maintenance therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., De Braud, F. & Pietrantonio, F., 2019, In : Journal of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Neutropenia
Ovarian Neoplasms
Drug Therapy
Neoplasms
Therapeutics

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., Jul 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Neutropenia
Ovarian Neoplasms
Drug Therapy
Neoplasms
Therapeutics

Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018

Marandino, L., De Luca, E., Zichi, C., Lombardi, P., Reale, M. L., Pignataro, D., Di Stefano, R. F., Ghisoni, E., Mariniello, A., Trevisi, E., Leone, G., Muratori, L., La Salvia, A., Sonetto, C., Buttigliero, C., Tucci, M., Aglietta, M., Novello, S., Scagliotti, G. V., Perrone, F. & 1 others, Di Maio, M., 2019, In : Clinical Genitourinary Cancer.

Research output: Contribution to journalReview article

Prostatic Neoplasms
Quality of Life
Pharmaceutical Preparations
Castration
Publications

Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018

Marandino, L., De Luca, E., Zichi, C., Lombardi, P., Reale, M. L., Pignataro, D., Di Stefano, R. F., Ghisoni, E., Mariniello, A., Trevisi, E., Leone, G., Muratori, L., La Salvia, A., Sonetto, C., Buttigliero, C., Tucci, M., Aglietta, M., Novello, S., Scagliotti, G. V., Perrone, F. & 1 others, Di Maio, M., Oct 2019, In : Clinical Genitourinary Cancer. 17, 5, p. 332-347.e2

Research output: Contribution to journalReview article

Prostatic Neoplasms
Quality of Life
Pharmaceutical Preparations
Castration
Publications

The great debate at "melanoma Bridge 2018", Naples, December 1st, 2018

Ascierto, P. A., Bruzzi, P., Eggermont, A., Hamid, O., Tawbi, H. A., Van Akkooi, A., Testori, A., Caracò, C., Puzanov, I. & Perrone, F., May 10 2019, In : Journal of Translational Medicine. 17, 1, 148.

Research output: Contribution to journalArticle

Open Access
CTLA-4 Antigen
Melanoma
Ligands
Pharmaceutical Preparations
Neoadjuvant Therapy

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

MITO Investigators, Jun 2019, In : Gynecologic Oncology. 153, 3, p. 535-540 6 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Uterine Cervical Neoplasms
Disease-Free Survival
Epidermal Growth Factor Receptor

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

Pignata, S., Scambia, G., Lorusso, D., De Giorgi, U., Nicoletto, M. O., Lauria, R., Mosconi, A. M., Sacco, C., Omarini, C., Tagliaferri, P., Ferrandina, G., Cinieri, S., Savarese, A., Valabrega, G., Pisano, C., Salutari, V., Raspagliesi, F., Kopf, B., Cecere, S. C., Amadio, G. & 11 others, Maltese, G., Di Napoli, M., Greggi, S., Signoriello, S., Daniele, G., Sacco, A., Losito, S., Normanno, N., Perrone, F., Gallo, C. & Piccirillo, M. C., 2019, In : Gynecologic Oncology. 153, 3, p. 535-540 6 p.

Research output: Contribution to journalArticle

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.

Pignata, S., Scambia, G., Lorusso, D., De Giorgi, U., Nicoletto, M. O., Lauria, R., Mosconi, A. M., Sacco, C., Omarini, C., Tagliaferri, P., Ferrandina, G., Cinieri, S., Savarese, A., Valabrega, G., Pisano, C., Salutari, V., Raspagliesi, F., Kopf, B., Cecere, S. C., Amadio, G. & 12 others, Maltese, G., Di Napoli, M., Greggi, S., Signoriello, S., Daniele, G., Sacco, A., Losito, S., Normanno, N., Perrone, F., Gallo, C., Piccirillo, M. C. & Investigators, MITO., Jun 1 2019, In : Gynecologic Oncology. 153, p. 535-540 6 p.

Research output: Contribution to journalArticle

The presence of concomitant mutations affects the activity of egfr tyrosine kinase inhibitors in egfr-mutant non-small cell lung cancer (Nsclc) patients

Rachiglio, A. M., Fenizia, F., Piccirillo, M. C., Galetta, D., Crinò, L., Vincenzi, B., Barletta, E., Pinto, C., Ferraù, F., Lambiase, M., Montanino, A., Roma, C., Ludovini, V., Montagna, E. S., Luca, A. D., Rocco, G., Botti, G., Perrone, F., Morabito, A. & Normanno, N., Mar 1 2019, In : Cancers. 11, 3, 341.

Research output: Contribution to journalArticle

Open Access
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Mutation
Disease-Free Survival
erbB-1 Genes

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

Rachiglio, A. M., Fenizia, F., Piccirillo, M. C., Galetta, D., Crinò, L., Vincenzi, B., Barletta, E., Pinto, C., Ferraù, F., Lambiase, M., Montanino, A., Roma, C., Ludovini, V., Montagna, E. S., De Luca, A., Rocco, G., Botti, G., Perrone, F., Morabito, A. & Normanno, N., Mar 10 2019, In : Cancers. 11, 3

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Mutation
Disease-Free Survival
erbB-1 Genes
2018
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cognetti, F., Montemurro, F., Bernardo, A., Gravina, A., Nuzzo, F. & Perrone, F., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 209 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Bisagni, G., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Cartenì, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'arco, A. M., D'auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, A., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P., Di Stefano, A., Diana, A., Donati, S., Fabbri, A., Fabi, A., Faedi, M., Farina, G., Farris, A., Febbraro, A., Fedele, P., Federico, P., Ferraù, F., Ferretti, G., Ferro, A., Floriani, I., Forcignanò, R., Forciniti, S., Forestieri, V., Fornari, G., Frisinghelli, M., Fusco, V., Gallizzi, G., Galvano, A., Gambardella, A., Gambi, A., Gebbia, V., Gervasi, E., Ghilardi, M., Giacobino, A., Giardina, G., Giotta, F., Giraudi, S., Giuliano, M., Grassadonia, A., Grasso, D., Grosso, F., Guizzaro, L., Incoronato, P., Incorvaia, L., Iodice, G., La Verde, N., Labonia, V., Landi, G., Latorre, A., Leonardi, V., Levaggi, A., Limite, G., Lina Bascialla, L., Livi, L., Maiello, E., Mandelli, D., Marcon, I., Menon, D., Montedoro, M., Moraca, L., Moretti, A., Morritti, M. G., Morselli, P., Mura, A., Mura, S., Musacchio, M., Muzio, A., Natale, D., Natoli, C., Nigro, C., Nisticò, C., Nuzzo, A., Orditura, M., Orlando, L., Pacilio, C., Palumbo, G., Palumbo, R., Pasini, F., Paterno, E., Pazzola, A., Pelliccioni, S., Pensabene, M., Perroni, D., Pesenti Gritti, A., Petrelli, F., Piccirillo, M. C., Pinotti, G., Pogliani, C., Poli, D., Prader, S., Recchia, F., Rizzi, D., Romano, C., Rossello, R., Rossini, C., Salvucci, G., Sanna, V., Santini, A., Saracchini, S., Savastano, C., Scambia, G., Schettini, F., Schiavone, P., Schirone, A., Seles, E., Signoriello, S., Signoriello, G., Silva, R. R., Silvestri, A., Simeon, V., Spagnoletti, I., Tamberi, S., Teragni, C., Thalmann, V., Thomas, R., Thomas, G., Tienghi, A., Tinari, N., Tinessa, V., Tomei, F., Tonini, G., Torri, V., Traficante, D., Tudini, M., Turazza, M., Vignoli, R., Vitale, M. G., Zacchia, A., Zagarese, P., Zanni, A., Zavallone, L., Zavettieri, M., Zoboli, A. & Investigators, GIM., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials

Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M. & 10 others, Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C. & Perrone, F., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2585-2592 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cisplatin
gemcitabine
Pemetrexed
Therapeutics

Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials

Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M. & 10 others, Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C. & Perrone, F., 2018, In : Journal of Clinical Oncology. 36, 25, p. 2585-2592 8 p.

Research output: Contribution to journalArticle

Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials

Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M. & 10 others, Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C. & Perrone, F., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2585-2592 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cisplatin
gemcitabine
Pemetrexed
Therapeutics

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016

Marandino, L., La Salvia, A., Sonetto, C., De Luca, E., Pignataro, D., Zichi, C., Di Stefano, R. F., Ghisoni, E., Lombardi, P., Mariniello, A., Reale, M. L., Trevisi, E., Leone, G., Muratori, L., Marcato, M., Bironzo, P., Novello, S., Aglietta, M., Scagliotti, G. V., Perrone, F. & 1 others, Di Maio, M., Dec 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, 12, p. 2288-2295 8 p.

Research output: Contribution to journalArticle

Quality of Life
Publications
Neoplasms
PubMed

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

Cavalieri, S., Perrone, F., Miceli, R., Ascierto, P. A., Locati, L. D., Bergamini, C., Granata, R., Alfieri, S., Resteghini, C., Galbiati, D., Busico, A., Paielli, N., Patuzzo, R., Maurichi, A., Gallino, G., Ruggeri, R., Mariani, L., Palla, M., Licitra, L. & Bossi, P., Jul 2018, In : European Journal of Cancer. 97, p. 7-15 9 p.

Research output: Contribution to journalArticle

Squamous Cell Neoplasms
Skin Neoplasms
Epidermal Growth Factor Receptor
Safety
Radiotherapy

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) & Perrone, F., 2018, In : The Lancet Oncology.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Meta-Analysis
Breast Neoplasms
Drug Therapy
Recurrence

Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study

Chiofalo, M. G., Signoriello, S., Fulciniti, F., Avenia, N., Ristagno, S., Lombardi, C. P., Nicolosi, A., Pelizzo, M. R., Perigli, G., Polistena, A., Panebianco, V., Bellantone, R., Calò, P. G., Boschin, I. M., Badii, B., Di Maio, M., Gallo, C., Perrone, F. & Pezzullo, L., 2018, In : Endocrine. p. 1-8 8 p.

Research output: Contribution to journalArticle

Thyroid Nodule
Multicenter Studies
Prospective Studies
Cell Biology
Neoplasms

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinumbased chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

Piccirillo, M. C., Scambia, G., Bologna, A., Signoriello, S., Vergote, I., Baumann, K., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Gallo, C., Pignata, S. & Perrone, F., 2018, In : Annals of Oncology. 29, 5, p. 1189-1194 6 p.

Research output: Contribution to journalArticle

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinumbased chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

Piccirillo, M. C., Scambia, G., Bologna, A., Signoriello, S., Vergote, I., Baumann, K., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Gallo, C., Pignata, S. & Perrone, F., May 1 2018, In : Annals of Oncology. 29, 5, p. 1189-1194 6 p.

Research output: Contribution to journalArticle

Platinum
Ovarian Neoplasms
Quality of Life
Drug Therapy
Arm
Platinum
Ovarian Neoplasms
Quality of Life
Drug Therapy
Arm
irinotecan
temozolomide
Salvage Therapy
Methyltransferases
DNA Methylation
2017

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Pan, H., Gray, R., Braybrooke, J., Davies, C., Taylor, C., McGale, P., Peto, R., Pritchard, K. I., Bergh, J., Dowsett, M., Hayes, D. F., EBCTCG & Perrone, F., Nov 9 2017, In : New England Journal of Medicine. 377, 19, p. 1836-1846 11 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Recurrence
Therapeutics
Neoplasms
Estrogen Receptors

A case where switching the end points for clinical trial interpretation might be the right choice

Perrone, F., Di Maio, M. & Del Mastro, L., Jun 1 2017, In : JAMA oncology. 3, 6, p. 735-736 2 p.

Research output: Contribution to journalComment/debate

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

Morabito, A., Daniele, G., Costanzo, R., Favaretto, A. G., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Sandomenico, C., Bonanno, L., Piazza, E., Maione, P., Piccirillo, M. C., Di Maio, M., Rocco, G., Gallo, C., Perrone, F. & Gridelli, C., Jun 1 2017, In : Lung Cancer. 108, p. 15-21 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Disease-Free Survival
Drug Therapy

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

Morabito, A., Daniele, G., Costanzo, R., Favaretto, A. G., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Sandomenico, C., Bonanno, L., Piazza, E., Maione, P., Piccirillo, M. C., Di Maio, M., Rocco, G., Gallo, C., Perrone, F. & Gridelli, C., Jun 2017, In : Lung Cancer. 108, p. 15-21 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Disease-Free Survival
Drug Therapy

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

Morabito, A., Daniele, G., Costanzo, R., Favaretto, A. G., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Sandomenico, C., Bonanno, L., Piazza, E., Maione, P., Piccirillo, M. C., Di Maio, M., Rocco, G., Gallo, C., Perrone, F. & Gridelli, C., 2017, In : Lung Cancer. 108, p. 15-21 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Disease-Free Survival
Drug Therapy
docetaxel
angiogenesis
Histology
Angiogenesis Inhibitors
Non-Small Cell Lung Carcinoma

Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients

Kim, L., Saieg, M., Di Maio, M., Gallo, C., Butts, C., Ciardiello, F., Feld, R., Cheng, D., Gebbia, V., Burgio, M. A., Alam, Y., Signoriello, S., Rossi, A., Leighl, N., Maione, P., Morabito, A., Liu, G., Tsao, M-S., Perrone, F. & Gridelli, C., Aug 22 2017, In : Oncotarget. 8, 34, p. 57528-57536 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Biomarkers
Drug Therapy
Disease-Free Survival
Mutation

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial

Daniele, G., Lorusso, D., Scambia, G., Cecere, S. C., Nicoletto, M. O., Breda, E., Colombo, N., Artioli, G., Cannella, L., Lo Re, G., Raspagliesi, F., Maltese, G., Salutari, V., Ferrandina, G., Greggi, S., Baldoni, A., Bergamini, A., Piccirillo, M. C., Tognon, G., Floriani, I. & 3 others, Signoriello, S., Perrone, F. & Pignata, S., Feb 1 2017, In : Gynecologic Oncology. 144, 2, p. 256-259 4 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Drug Therapy
Surgical Wound Dehiscence
Bevacizumab

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial

Daniele, G., Lorusso, D., Scambia, G., Cecere, S. C., Nicoletto, M. O., Breda, E., Colombo, N., Artioli, G., Cannella, L., Lo Re, G., Raspagliesi, F., Maltese, G., Salutari, V., Ferrandina, G., Greggi, S., Baldoni, A., Bergamini, A., Piccirillo, M. C., Tognon, G., Floriani, I. & 3 others, Signoriello, S., Perrone, F. & Pignata, S., Feb 2017, In : Gynecologic Oncology. 144, 2, p. 256-259 4 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Drug Therapy
Surgical Wound Dehiscence
Bevacizumab

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the

Daniele, G., Lorusso, D., Scambia, G., Cecere, S. C., Nicoletto, M. O., Breda, E., Colombo, N., Artioli, G., Cannella, L., Lo Re, G., Raspagliesi, F., Maltese, G., Salutari, V., Ferrandina, G., Greggi, S., Baldoni, A., Bergamini, A., Piccirillo, M. C., Tognon, G., Floriani, I. & 3 others, Signoriello, S., Perrone, F. & Pignata, S., Feb 1 2017, In : Gynecologic Oncology. 144, 2, p. 256-259 4 p.

Research output: Contribution to journalArticle

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial

Daniele, G., Lorusso, D., Scambia, G., Cecere, S. C., Nicoletto, M. O., Breda, E., Colombo, N., Artioli, G., Cannella, L., Lo Re, G., Raspagliesi, F., Maltese, G., Salutari, V., Ferrandina, G., Greggi, S., Baldoni, A., Bergamini, A., Piccirillo, M. C., Tognon, G., Floriani, I. & 3 others, Signoriello, S., Perrone, F. & Pignata, S., 2017, In : Gynecologic Oncology. 144, 2, p. 256-259 4 p.

Research output: Contribution to journalArticle